期刊文献+

肿瘤细胞来源的外泌体与恶性肿瘤的进展及化疗 被引量:13

Tumor Cells-derived Exosome on Tumor Malignant Progression and Chemotherapy
下载PDF
导出
摘要 外泌体是细胞分泌的一种纳米级囊泡结构,在血液、唾液、尿液等多种体液中均有分布.作为一类重要的细胞间通信分子,外泌体含有多种具有生物活性的成分,可通过多种方式在人体中发挥调节作用.目前在多种类型的细胞中均发现外泌体的存在,而肿瘤细胞来源的外泌体由于其本身的特性和功能特点,可通过微环境介导肿瘤细胞的增生、血管形成和免疫耐受,并可通过介导上皮-间质转化(epithelial-mesenchymal transition,EMT)和胞内药物排斥反应等增加肿瘤细胞的化疗抵抗能力.同时,因其含有肿瘤细胞所分泌的特异性成分,因而可通过对外泌体中相关分子改变的检测,对疾病进行诊断和监测,并可为临床个体化用药提供新思路. Exosomes are nano scale vesicles secreted by cells. Exosomes existed in body fluids, such as blood, saliva,urine and cerebrospinal fluid. As an important signaling mediator of cell communication, many exosome constituents serve as regulators with different biological activities or functions. So far, exosomes have been found in various types of cells, including tumor cells. Exosomes can participate in tumor cell proliferation, vascularization and immune tolerance by affecting cell microenvironment. Exosomes may also facilitate tumor chemoresistance by mediating EMT and increasing intracellular drug expulsion. Specific component of the tumor cellsderived exosomes can be used in diagnosing diseases, as well as providing new means for individualized cancer treatments.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2014年第6期526-532,共7页 Chinese Journal of Biochemistry and Molecular Biology
基金 国家自然科学基金项目(No.81272297)资助~~
关键词 外泌体 化疗抵抗 肿瘤微环境 MIRNA 免疫耐受 exosomes chemoresistance microenvironment microRNA immune tolerance
  • 相关文献

参考文献59

  • 1刘儒涛,王世伟,刘晶.细胞间信息交流的新载体——外泌体[J].生物化学与生物物理进展,2013,40(8):719-727. 被引量:11
  • 2Mittelbrunn M,S6nchez-Madrid F.Intercellular communication:diverse structures for exchange of genetic information[J].NatRev Mol Cell Biol,2012,13(5):328-335.
  • 3Vlassov A V,Magdaleno S,Setterquist R,et al.Exosomes:current knowledge of their composition,biological functions,anddiagnostic and therapeutic potentials[J].Biochim Biophys Acta,2012,1820(7):940-948.
  • 4Corrado C,Raimondo S,Chiesi A,et al.Exosomes asintercellular signaling organelles involved in health and disease:basic science and clinical applications[J].Int J Mol Sci,2013,14(3):5338-5366.
  • 5D'Souza-Schorey C,Clancy J W.Tumor-derived microvesicles:shedding light on novel microenvironment modulators andprospective cancer biomarkers[J].Genes Dev,2012,26(12):1287-1299.
  • 6Th6ry C,Zitvogel L,Amigorena S.Exosomes:composition,biogenesis and function[J].Nat Rev Immunol,2002,2(8):569-579.
  • 7Chen T S,Arslan F,Yin Y,et al.Enabling a robust scalablemanufacturing process for therapeutic exosomes through oncogenicimmortalization of human ESC-derived MSCs[J].J Transl Med,2011,9(47):1471-1482.
  • 8Hao S,Bai 0,Li F,et al.Mature dendritic cells pulsed withexosomes stimulate efficient cytotoxic T-lymphocyte responsesand antitumour immunity[J].Immunology,2007,120(1):90-102.
  • 9Zhu M,Li Y,Shi J,et al.Exosomes as extrapulmonarysignaling conveyors for nanoparticle-induced systemic immuneactivation[J].Small,2012,8(3):404-412.
  • 10Cai Z,Yang F,Yu L,et al.Activated T cell exosomes promotetumor invasion via Fas signaling pathway[J].J Immunol,2012,88(12):5954-5961.

二级参考文献65

  • 1Wolfers J,Lozier A,Raposo G,et al.Tumer-derived exosomes are a shared tumor rejection antigens for CTL cross-priming[J].Nat Med,2001,7:297-303.
  • 2Clayton A,Mitchell JP,Court J,et al.Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2[J].Cancer Res,2007,67:7458-7466.
  • 3Qu JL,Qu XJ,Zhao MF,et al.The role of cbl family of ubiquitin ligases in gastric cancer exosome-induced apoptosis of Jurkat T cells[J].Acta Oncol,2009,48:1173-1180.
  • 4Al-Nedawi K,Meehan B,Micallef J,et al.Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells[J].Nat Cell Biol,2008,10:619-624.
  • 5Skog J,W黵dinger T,van Rijn S,et al.Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers[J].Nat Cell Biol,2008,10:1470-1476.
  • 6Lamparski HG,Metha-Damani A,Yao JY,et al.Production and characterization of clinical grade exosomes derived from dendritic cells[J].J Immunol Meth,2002,270:211-226.
  • 7Liu C,Yu S,Zinn K,et al.Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function[J].J Immunol,2006,176:1375-1385.
  • 8Vincent-Schneider H,Stumptner-Cuvelette P,Lankar D,et al.Exosomes bearing HLA-DR1 molecules need dendritic cells to efficiently stimulate specific T cells[J].Int Immunol,2002,14:713-722.
  • 9Ghayad SE,Cohen PA.Inhibitors of the PI3K/Akt/mTOR pathway:new hope for breast cancer patients[J].Recent Pat Anticancer Drug Discov,2010,5:29-57.
  • 10Maemura K,Shiraishi N,Sakagami K,et al.Proliferative effects of gamma-aminobutyric acid on the gastric cancer cell line are associated with extracellular signal-regulated kinase 1/2 activation[J].J Gastroenterol Hepatol,2009,24:688-696.

共引文献22

同被引文献116

  • 1卞锋,江漫清,桑永英.虚拟现实及其应用进展[J].计算机仿真,2007,24(6):1-4. 被引量:58
  • 2Burner FM. The concept of immunologieal surveillance [ J ]. Prog Exp Tumor Res , 1970,13 : 1227.
  • 3Shresta S, Pham CT, Thomas DA, et al. How do cytotoxic lympho- cytes kill their targets [ J ]. Curr Opin lmmunol, 1998,10 ( 5 ) : 581-587.
  • 4Igney FH,Krammer PH. Immune escape of tumors: apoptosis re- sistance and tumor counterattack [ J ]. J Leukoc Biol , 2002,71 (6) :907-920.
  • 5Hicklin DJ, Marincola FM, Ferrone S. HLA class I antigen down- regulation in human ancers: T-cell immunotherapy revives an old story[J]. Mol Med Today,1999,5(4) :178-186.
  • 6Angell TE, Lechner MG, Jang JK, et al. MHC class I loss is a fre- quent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitro [ J ]. Clin Cancer Res,2014,20 ( 23 ) :6034-6044.
  • 7Prineipe DR, Doll JA, Bauer J, et al. TGF- : duality of function between tumor prevention and carcinogenesis [ .J ]. J Natl Cancer Inst ,2014,106 (2) : djt369.
  • 8Gorelik L, Flavell RA. Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells[ J]. Nat Med,2001,7(10) :1118-1122.
  • 9Bolpetti A, Silva JS, Villa LL, et al. Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papilloma- virus 16 tumor growth [ J ]. BMC lmmtmol,2010 ,11:27.
  • 10Staveley-OCarroll K, Sotomayor E, Montgomery J, et al. Induction of antigen-specific T cell anerg'y : An early event in the course of tumor progression [ J ]. Proc Natl Acad Sci USA, 1998,95 ( 3 ) : 1178-1183.

引证文献13

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部